Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 01-2013 | 12-2012 | |
| Sales | 133 | 197 | 150 | 31,021 | 213 |
| Cost of Goods | 1,598 | 1,251 | 1,234 | 19,091 | 1,989 |
| Gross Profit | -1,465 | -1,054 | -1,084 | 11,930 | -1,776 |
| Operating Expenses | 15,783 | 18,296 | 16,317 | 10,230 | 19,553 |
| Operating Income | -16,650 | -19,099 | -17,167 | 1,791 | -20,340 |
| Interest Expense | 3 | 11 | 16 | 258 | 24 |
| Other Income | 1,423 | 1,660 | 958 | 1,909 | 3,010 |
| Pre-tax Income | -15,230 | -17,450 | -16,225 | 3,442 | -17,354 |
| Income Tax | N/A | N/A | N/A | 920 | N/A |
| Net Income Continuous | -15,230 | -17,450 | -16,225 | 2,522 | -17,354 |
| Net Income | $-15,230 | $-17,450 | $-16,225 | $2,522 | $-17,354 |
| EPS Basic Total Ops | -3,392.07 | -4,889.87 | -5,288.46 | 0.67 | -6,346.15 |
| EPS Basic Continuous Ops | -3,409.35 | -4,899.13 | -5,128.03 | 0.67 | -6,508.15 |
| EPS Diluted Total Ops | -3,392.07 | -4,889.87 | -5,288.46 | 0.62 | -6,346.15 |
| EPS Diluted Continuous Ops | -3,409.35 | -4,899.13 | -5,128.03 | 0.62 | -6,508.15 |
| EBITDA(a) | $-15,460 | $-17,957 | $-16,300 | $2,373 | $-19,657 |